News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
570,478 Results
Type
Article (41365)
Company Profile (82)
Press Release (529020)
Multimedia
Podcasts (79)
Webinars (18)
Section
Business (152392)
Career Advice (2455)
Deals (27857)
Drug Delivery (120)
Drug Development (73289)
Employer Resources (141)
FDA (13917)
Job Trends (12288)
News (272540)
Policy (27154)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2568)
Academic (1)
Accelerated approval (43)
Adcomms (31)
Allergies (160)
Alliances (38473)
ALS (197)
Alzheimer's disease (1759)
Antibody-drug conjugate (ADC) (413)
Approvals (14230)
Artificial intelligence (584)
Autoimmune disease (232)
Automation (45)
Bankruptcy (311)
Best Places to Work (9997)
BIOSECURE Act (16)
Biosimilars (194)
Biotechnology (61)
Bladder cancer (180)
Brain cancer (64)
Breast cancer (680)
Cancer (5364)
Cardiovascular disease (454)
Career advice (2086)
Career pathing (41)
CAR-T (292)
CDC (54)
Cell therapy (789)
Cervical cancer (37)
Clinical research (63826)
Collaboration (1708)
Company closure (5)
Compensation (678)
Complete response letters (83)
COVID-19 (2601)
CRISPR (93)
C-suite (1089)
Cystic fibrosis (128)
Data (7198)
Decentralized trials (3)
Denatured (12)
Depression (166)
Dermatology (69)
Diabetes (546)
Diagnostics (6200)
Digital health (43)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (261)
Drug pricing (183)
Drug shortages (27)
Duchenne muscular dystrophy (273)
Earnings (58783)
Editorial (62)
Employer branding (18)
Employer resources (133)
Events (79713)
Executive appointments (1060)
FDA (17243)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1447)
Gene editing (208)
Generative AI (54)
Gene therapy (679)
GLP-1 (1016)
Government (4418)
Grass and pollen (7)
Guidances (399)
Healthcare (16096)
HIV (75)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (295)
Immuno-oncology (82)
Indications (158)
Infectious disease (2916)
Inflammatory bowel disease (195)
Inflation Reduction Act (13)
Influenza (125)
Intellectual property (262)
Interviews (528)
IPO (12632)
IRA (49)
Job creations (2588)
Job search strategy (1677)
JPM (56)
Kidney cancer (20)
Labor market (67)
Layoffs (514)
Leadership (43)
Legal (5782)
Liver cancer (97)
Longevity (24)
Lung cancer (746)
Lymphoma (401)
Machine learning (48)
Management (51)
Manufacturing (828)
MASH (196)
Medical device (11005)
Medtech (11079)
Mergers & acquisitions (16299)
Metabolic disorders (1421)
mRNA (176)
Multiple sclerosis (176)
NASH (24)
Neurodegenerative disease (393)
Neuropsychiatric disorders (108)
Neuroscience (3193)
Neurotech (1)
NextGen: Class of 2026 (5539)
Non-profit (4020)
Now hiring (63)
Obesity (651)
Opinion (289)
Ovarian cancer (200)
Pain (233)
Pancreatic cancer (276)
Parkinson's disease (338)
Partnered (28)
Patents (540)
Patient recruitment (608)
Peanut (54)
People (52903)
Pharmaceutical (19)
Pharmacy benefit managers (19)
Phase 1 (19644)
Phase 2 (28063)
Phase 3 (21409)
Pipeline (7430)
Policy (297)
Postmarket research (2316)
Preclinical (8058)
Press Release (54)
Prostate cancer (276)
Psychedelics (60)
Radiopharmaceuticals (284)
Rare diseases (1001)
Real estate (4140)
Recruiting (60)
Regulatory (21829)
Reports (32)
Research institute (2185)
Resumes & cover letters (359)
Rett syndrome (35)
RNA editing (20)
RSV (78)
Schizophrenia (176)
Series A (245)
Series B (178)
Service/supplier (3)
Sickle cell disease (108)
Special edition (20)
Spinal muscular atrophy (165)
Sponsored (43)
Startups (2788)
State (2)
Stomach cancer (19)
Supply chain (105)
Tariffs (75)
The Weekly (65)
Vaccines (1000)
Venture capital (97)
Weight loss (436)
Women's health (96)
Worklife (20)
Date
Today (154)
Last 7 days (646)
Last 30 days (2472)
Last 365 days (26567)
2026 (8955)
2025 (26507)
2024 (30560)
2023 (34106)
2022 (44532)
2021 (47772)
2020 (46287)
2019 (39635)
2018 (30035)
2017 (26953)
2016 (25620)
2015 (29992)
2014 (22453)
2013 (18242)
2012 (19474)
2011 (20495)
2010 (18091)
Location
Africa (736)
Alabama (82)
Alaska (4)
Arizona (237)
Arkansas (12)
Asia (35228)
Australia (7327)
California (10466)
Canada (3301)
China (1204)
Colorado (453)
Connecticut (440)
Delaware (353)
Europe (79249)
Florida (1704)
Georgia (340)
Hawaii (1)
Idaho (53)
Illinois (886)
India (80)
Indiana (503)
Iowa (18)
Japan (475)
Kansas (115)
Kentucky (38)
Louisiana (36)
Maine (59)
Maryland (1337)
Massachusetts (7259)
Michigan (307)
Minnesota (527)
Mississippi (5)
Missouri (133)
Montana (26)
Nebraska (25)
Nevada (124)
New Hampshire (79)
New Jersey (3032)
New Mexico (21)
New York (2854)
North Carolina (1302)
North Dakota (6)
Northern California (5146)
Ohio (312)
Oklahoma (13)
Oregon (30)
Pennsylvania (2182)
Puerto Rico (27)
Rhode Island (39)
South America (999)
South Carolina (78)
South Dakota (2)
Southern California (4229)
Tennessee (171)
Texas (1772)
United States (37680)
Utah (348)
Vermont (1)
Virginia (270)
Washington D.C. (65)
Washington State (887)
West Virginia (4)
Wisconsin (100)
Wyoming (2)
570,478 Results for "circulogene formerly known as circulogene theranostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Circulogene Expands Solid Tumor Genomic Capabilities with Launch of OncoGenDx Tissue Assay
October 7, 2025
·
2 min read
Press Releases
Radiopharm Theranostics Reports Business Update
April 23, 2026
·
8 min read
Press Releases
Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.
April 7, 2026
·
3 min read
Press Releases
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
April 20, 2026
·
5 min read
Press Releases
Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
April 8, 2026
·
2 min read
Press Releases
Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases
April 16, 2026
·
4 min read
Press Releases
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
·
13 min read
Press Releases
Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer
March 27, 2026
·
3 min read
Press Releases
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates
January 28, 2026
·
8 min read
Press Releases
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
February 24, 2026
·
4 min read
1 of 57,048
Next
